Related Experiment Video
Updated: May 15, 2026

07:59
A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes
Published on: March 25, 2014
T-cell epitope vaccine design by immunoinformatics
Atanas Patronov1, Irini Doytchinova
1Department of Chemistry, Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria.
Open Biology
|January 11, 2013
Summary
Vaccines prevent infectious diseases by stimulating the immune system with pathogen components. Advances in bioinformatics and immunoinformatics enable the design of targeted peptide vaccines using epitope identification.
Area of Science:
- Immunology
- Bioinformatics
- Vaccinology
Background:
- Vaccination is a primary strategy for infectious disease prevention.
- Vaccines function by presenting antigens to the immune system to elicit a response.
- Modern vaccine development utilizes molecular-level understanding of antigen recognition.
Purpose of the Study:
- To review the role of immunoinformatics in vaccine design.
- To discuss the principles and methods of peptide vaccine development.
- To highlight the application of bioinformatics in immunology.
Main Methods:
- Review of sequence- and structure-based immunoinformatics methods.
- Discussion of epitope identification and chemical synthesis for peptide vaccines.
- Exploration of in silico analysis and modeling of immunological data.
Main Results:
- Peptide vaccines are rationally designed using identified B-cell and T-cell epitopes.
- Immunoinformatics provides tools for analyzing and modeling immunological data.
- The field integrates bioinformatics with immunology for vaccine research.
Conclusions:
- Peptide vaccines represent a rational approach to vaccine design.
- Immunoinformatics is crucial for advancing vaccine development through computational methods.
- Understanding epitopes is key to creating specific and effective immune responses.
Related Concept Videos
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Antigens Involved in Adaptive Immunity
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.

